nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Cholelithiasis—Leflunomide—systemic scleroderma	0.0162	0.0162	CcSEcCtD
Pasireotide—Amylase increased—Mycophenolate mofetil—systemic scleroderma	0.0159	0.0159	CcSEcCtD
Pasireotide—Cholelithiasis—Mycophenolate mofetil—systemic scleroderma	0.0122	0.0122	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Mycophenolic acid—systemic scleroderma	0.0116	0.0116	CcSEcCtD
Pasireotide—Diabetes mellitus—Captopril—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Pasireotide—Abdominal distension—Pentoxifylline—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Mycophenolic acid—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00919	0.00919	CcSEcCtD
Pasireotide—Nasopharyngitis—Mometasone—systemic scleroderma	0.00901	0.00901	CcSEcCtD
Pasireotide—Influenza—Mometasone—systemic scleroderma	0.0087	0.0087	CcSEcCtD
Pasireotide—Diabetes mellitus—Leflunomide—systemic scleroderma	0.00838	0.00838	CcSEcCtD
Pasireotide—Diabetes mellitus—Mycophenolic acid—systemic scleroderma	0.008	0.008	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Mycophenolate mofetil—systemic scleroderma	0.00799	0.00799	CcSEcCtD
Pasireotide—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00752	0.00752	CcSEcCtD
Pasireotide—Diabetes mellitus—Lisinopril—systemic scleroderma	0.0072	0.0072	CcSEcCtD
Pasireotide—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.00713	0.00713	CcSEcCtD
Pasireotide—Pain in extremity—Mycophenolic acid—systemic scleroderma	0.00696	0.00696	CcSEcCtD
Pasireotide—Back pain—Pentoxifylline—systemic scleroderma	0.0068	0.0068	CcSEcCtD
Pasireotide—Dry skin—Leflunomide—systemic scleroderma	0.00668	0.00668	CcSEcCtD
Pasireotide—Hypokalaemia—Leflunomide—systemic scleroderma	0.00664	0.00664	CcSEcCtD
Pasireotide—Anaemia—Pentoxifylline—systemic scleroderma	0.0065	0.0065	CcSEcCtD
Pasireotide—Hypoglycaemia—Lisinopril—systemic scleroderma	0.00642	0.00642	CcSEcCtD
Pasireotide—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Pasireotide—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.00633	0.00633	CcSEcCtD
Pasireotide—Diabetes mellitus—Mycophenolate mofetil—systemic scleroderma	0.00631	0.00631	CcSEcCtD
Pasireotide—Influenza—Leflunomide—systemic scleroderma	0.0063	0.0063	CcSEcCtD
Pasireotide—Pain in extremity—Lisinopril—systemic scleroderma	0.00626	0.00626	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.00626	0.00626	CcSEcCtD
Pasireotide—Nasopharyngitis—Mycophenolic acid—systemic scleroderma	0.00622	0.00622	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.00613	0.00613	CcSEcCtD
Pasireotide—Hypertension—Pentoxifylline—systemic scleroderma	0.00607	0.00607	CcSEcCtD
Pasireotide—Abdominal distension—Mycophenolic acid—systemic scleroderma	0.00605	0.00605	CcSEcCtD
Pasireotide—Influenza—Mycophenolic acid—systemic scleroderma	0.00601	0.00601	CcSEcCtD
Pasireotide—Myalgia—Pentoxifylline—systemic scleroderma	0.00598	0.00598	CcSEcCtD
Pasireotide—Anxiety—Pentoxifylline—systemic scleroderma	0.00596	0.00596	CcSEcCtD
Pasireotide—Back pain—Mometasone—systemic scleroderma	0.00587	0.00587	CcSEcCtD
Pasireotide—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00568	0.00568	CcSEcCtD
Pasireotide—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00562	0.00562	CcSEcCtD
Pasireotide—Nasopharyngitis—Lisinopril—systemic scleroderma	0.0056	0.0056	CcSEcCtD
Pasireotide—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00542	0.00542	CcSEcCtD
Pasireotide—Hypercholesterolaemia—Prednisone—systemic scleroderma	0.00542	0.00542	CcSEcCtD
Pasireotide—Influenza—Lisinopril—systemic scleroderma	0.00541	0.00541	CcSEcCtD
Pasireotide—Alopecia—Captopril—systemic scleroderma	0.00541	0.00541	CcSEcCtD
Pasireotide—Hypotension—Pentoxifylline—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00523	0.00523	CcSEcCtD
Pasireotide—Insomnia—Pentoxifylline—systemic scleroderma	0.00519	0.00519	CcSEcCtD
Pasireotide—Arthralgia—Mometasone—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Pasireotide—Myalgia—Mometasone—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Pasireotide—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.005	0.005	CcSEcCtD
Pasireotide—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Pasireotide—Oedema peripheral—Leflunomide—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Pasireotide—Anaemia—Captopril—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Pasireotide—Constipation—Pentoxifylline—systemic scleroderma	0.00491	0.00491	CcSEcCtD
Pasireotide—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Pasireotide—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Pasireotide—Influenza—Mycophenolate mofetil—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Pasireotide—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Pasireotide—Alopecia—Azathioprine—systemic scleroderma	0.00472	0.00472	CcSEcCtD
Pasireotide—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Pasireotide—Myalgia—Captopril—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Pasireotide—Arthralgia—Captopril—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Pasireotide—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00451	0.00451	CcSEcCtD
Pasireotide—Alopecia—Leflunomide—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Pasireotide—Decreased appetite—Mometasone—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Pasireotide—Anaemia—Azathioprine—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Pasireotide—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisone—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Pasireotide—Oedema peripheral—Lisinopril—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Pasireotide—Fatigue—Mometasone—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Pasireotide—Alopecia—Mycophenolic acid—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Pasireotide—Back pain—Leflunomide—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Pasireotide—Asthenia—Pentoxifylline—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Pasireotide—Hypotension—Captopril—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Pasireotide—Pruritus—Pentoxifylline—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Pasireotide—Anaemia—Leflunomide—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Pasireotide—Back pain—Mycophenolic acid—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Pasireotide—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Pasireotide—Myalgia—Azathioprine—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Pasireotide—Arthralgia—Azathioprine—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Pasireotide—Vertigo—Leflunomide—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Pasireotide—Insomnia—Captopril—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Pasireotide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Pasireotide—Abdominal pain—Mometasone—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Pasireotide—Anaemia—Mycophenolic acid—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Pasireotide—Alopecia—Lisinopril—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Pasireotide—Dizziness—Pentoxifylline—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Pasireotide—Hypertension—Leflunomide—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Pasireotide—Decreased appetite—Captopril—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Pasireotide—Vertigo—Mycophenolic acid—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Pasireotide—Fatigue—Captopril—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Pasireotide—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Pasireotide—Arthralgia—Leflunomide—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Pasireotide—Myalgia—Leflunomide—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Pasireotide—Anxiety—Leflunomide—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Pasireotide—Constipation—Captopril—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Pasireotide—Back pain—Lisinopril—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Pasireotide—Vomiting—Pentoxifylline—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Pasireotide—Hypertension—Mycophenolic acid—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Pasireotide—Headache—Pentoxifylline—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Pasireotide—Diabetes mellitus—Methotrexate—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Pasireotide—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Pasireotide—Myalgia—Mycophenolic acid—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Pasireotide—Gastrointestinal pain—Captopril—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Pasireotide—Anxiety—Mycophenolic acid—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Pasireotide—Asthenia—Mometasone—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Pasireotide—Hypotension—Azathioprine—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Pasireotide—Pruritus—Mometasone—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Pasireotide—Anaemia—Lisinopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Pasireotide—Abdominal pain—Captopril—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Pasireotide—Dry skin—Prednisone—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Pasireotide—Nausea—Pentoxifylline—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Pasireotide—Vertigo—Lisinopril—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Pasireotide—Diarrhoea—Mometasone—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Pasireotide—Hypokalaemia—Prednisone—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Pasireotide—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Pasireotide—Hypotension—Leflunomide—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Pasireotide—Insomnia—Leflunomide—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Pasireotide—Abdominal distension—Prednisone—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Pasireotide—Arthralgia—Lisinopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Pasireotide—Myalgia—Lisinopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Pasireotide—Anxiety—Lisinopril—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Pasireotide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Pasireotide—Hypotension—Mycophenolic acid—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Pasireotide—Vomiting—Mometasone—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Pasireotide—Asthenia—Captopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Pasireotide—Decreased appetite—Leflunomide—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Pasireotide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Pasireotide—Headache—Mometasone—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Pasireotide—Insomnia—Mycophenolic acid—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Pasireotide—Fatigue—Leflunomide—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Pasireotide—Pruritus—Captopril—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Pasireotide—Constipation—Leflunomide—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Pasireotide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Pasireotide—Abdominal pain—Azathioprine—systemic scleroderma	0.003	0.003	CcSEcCtD
Pasireotide—Diarrhoea—Captopril—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Pasireotide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Pasireotide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Pasireotide—Fatigue—Mycophenolic acid—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Pasireotide—Nausea—Mometasone—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Pasireotide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Pasireotide—Constipation—Mycophenolic acid—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Pasireotide—Hyperglycaemia—Prednisone—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Pasireotide—Hypotension—Lisinopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Pasireotide—Dizziness—Captopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Pasireotide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Pasireotide—Abdominal pain—Leflunomide—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Pasireotide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Pasireotide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Pasireotide—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Pasireotide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Pasireotide—Insomnia—Lisinopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Pasireotide—Vomiting—Captopril—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Pasireotide—Headache—Captopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Pasireotide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Pasireotide—Decreased appetite—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Pasireotide—Fatigue—Lisinopril—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Pasireotide—Constipation—Lisinopril—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Pasireotide—Diarrhoea—Azathioprine—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Pasireotide—Nausea—Captopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Pasireotide—Asthenia—Leflunomide—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Pasireotide—Pruritus—Leflunomide—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Pasireotide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Pasireotide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Pasireotide—Dizziness—Azathioprine—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Pasireotide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Pasireotide—Diarrhoea—Leflunomide—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Pasireotide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Pasireotide—Abdominal pain—Lisinopril—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Pasireotide—Pruritus—Mycophenolic acid—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Pasireotide—Vomiting—Azathioprine—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Pasireotide—Headache—Azathioprine—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Pasireotide—Dizziness—Leflunomide—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Pasireotide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Pasireotide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Pasireotide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Pasireotide—Vomiting—Leflunomide—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Pasireotide—Alopecia—Prednisone—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Pasireotide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Pasireotide—Nausea—Azathioprine—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Pasireotide—Headache—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Pasireotide—Asthenia—Lisinopril—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Pasireotide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Pasireotide—Pruritus—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Pasireotide—Vomiting—Mycophenolic acid—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Pasireotide—Headache—Mycophenolic acid—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Pasireotide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Pasireotide—Nausea—Leflunomide—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Pasireotide—Diarrhoea—Lisinopril—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Pasireotide—Anaemia—Prednisone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Pasireotide—Dizziness—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Pasireotide—Nausea—Mycophenolic acid—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Pasireotide—Vertigo—Prednisone—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Pasireotide—Vomiting—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Pasireotide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Pasireotide—Hypertension—Prednisone—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Pasireotide—Headache—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Pasireotide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Pasireotide—Arthralgia—Prednisone—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Pasireotide—Myalgia—Prednisone—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Pasireotide—Anxiety—Prednisone—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Pasireotide—Alopecia—Methotrexate—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Pasireotide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Pasireotide—Nausea—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Pasireotide—Back pain—Methotrexate—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Pasireotide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Pasireotide—Anaemia—Methotrexate—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Pasireotide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Pasireotide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Pasireotide—Vertigo—Methotrexate—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Pasireotide—Insomnia—Prednisone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Pasireotide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Pasireotide—Arthralgia—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Pasireotide—Myalgia—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Pasireotide—Decreased appetite—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Pasireotide—Fatigue—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Pasireotide—Constipation—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Pasireotide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Pasireotide—Abdominal pain—Prednisone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Pasireotide—Hypotension—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Pasireotide—Insomnia—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Pasireotide—Decreased appetite—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Pasireotide—Fatigue—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Pasireotide—Asthenia—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Pasireotide—Pruritus—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Pasireotide—Diarrhoea—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Pasireotide—Dizziness—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Pasireotide—Abdominal pain—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Pasireotide—Vomiting—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Pasireotide—Headache—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Pasireotide—Asthenia—Methotrexate—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Pasireotide—Nausea—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Pasireotide—Pruritus—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Pasireotide—Diarrhoea—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Pasireotide—Dizziness—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Pasireotide—Vomiting—Methotrexate—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Pasireotide—Headache—Methotrexate—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Pasireotide—Nausea—Methotrexate—systemic scleroderma	0.000908	0.000908	CcSEcCtD
